Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cancer Immunol Immunother. 2011 Dec 24;61(7):1125–1136. doi: 10.1007/s00262-011-1187-z

Fig. 5.

Fig. 5

PR1-specific CD8+ T-cell responses in patients vaccinated with WT1 peptide only following lymphodepletion. PR1-specific CD8+ T-cell responses (light blue line) are correlated with ELA-2/PR3 expression (dark blue line) and compared with WT1 vaccine-induced CD8+ T cells (red line)